CClinicalTrials.gg
Status unknownNCT03848897PrévSimUpdated Apr 16, 2019

Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients

An interventional study of Metrology of motor behavior in Aging Disorder and Parkinson Disease, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-16.

Sponsored by Central Hospital, Nancy, France · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Non-randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

The process of ageing affects at the same time the sensory, cognitive and driving functions. Furthermore, ageing is often accompanied by pathologies increasing the effects of the senescence. An ageing subject will have then more difficulties in maintaining balance control and will have a falling risk with sometimes critical consequences for the quality of life.

The risk of fall is estimated by tests at the same time of current life and with scores of sensitivity and specificity which must be improved. In a review including 25 studies (2 314 subjects), show a sensitivity of 32 % and a specificity of 73 % on the test "Timed Up and Go" (TUG) with a threshold at 13.5 seconds.

In addition, the fall occurs in a multifactorial context when a subject interacts with his environment. It therefore seems essential to test balance control or falling risk of individuals as close as possible to the situations of daily life. This research, based on the TUG, will aim to assess the neuro-psycho-motor behavior of subjects in situations close to daily life using a Virtual Reality (VR) and Human Metrology platform.

The results could ultimately lead to increased sensitivity and specificity in assessing the risk of falling with a TUG performed in VR, compared to the classic TUG, which is commonly used by healthcare professionals and thus allow for earlier or more appropriate management of the subject in preventing the risk of falling. This could allow healthcare professionals to better understand the risk of falling and thus guide medical recommendations and prescribing, particularly in terms of appropriate physical activity programs.

02

Conditions studied

  • Aging Disorder
  • Parkinson Disease

Browse trials for

Keywords

  • Virtual reality
  • Human metrology
  • Motor behavior
  • Modeling
  • Ageing
  • Parkinson's disease
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's planned enrollment of 116 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Non-faller elderly

  • Male and female
  • Age between 65 and 80 years old
  • Autonomous
  • Reporting no fall in the last 12 months

Fallers elderly

  • Male and female
  • Age between 65 and 80 years old
  • Autonomous
  • Reporting at least 1 fall in the last 12 months

Non-faller Patients with Parkinson's disease

  • Male and female
  • Age between 65 and 80 years old
  • Autonomous
  • Reporting no fall in the last 12 months
  • Dopa-sensitive
  • In ON period of treatment of Parkinson's disease

Exclusion criteria

Exclusion Criteria:

  • Hearing loss preventing understanding of the instructions and listening to the sound message
  • Visual acuity not compatible with the test procedure in virtual reality
  • Inability to move without assistance
  • Not understanding written and oral French, illiteracy, dementia
  • Treatment including psychotropic drugs
  • Person in emergency situation,
  • Major person subject to a legal protection measure (guardianship, curator, safeguard of justice),
  • Major person unable to express his consent,
  • Hospitalized person,
  • Person deprived of liberty by a judicial or administrative decision, the persons being the object of psychiatric care by virtue of articles L. 3212-1 and L. 3213-1 of the french Code of Public Health,
  • Person likely, in the opinion of the investigator, not to be cooperating or respectful of the obligations inherent to participation in the study
  • Person with a predisposition to epilepsy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
116 participants (estimated)

Study arms

  • Experimental
    Non falling elderly

    Other: Metrology of motor behavior

  • Experimental
    Falling elderly

    Other: Metrology of motor behavior

  • Experimental
    Non falling patients with Parkinson's disease

    Other: Metrology of motor behavior

Interventions

  • OtherMetrology of motor behavior

    Biomechanical, physiological, psychological and behavioral analyses

06

What researchers measure

Primary outcomes

  1. Timed Up & Go in virtual reality (VR)

    Time

    Time frame: Baseline

Secondary outcomes

  1. Timed Up & Go (non VR condition)

    Time

    Time frame: Baseline

  2. Validation of the TUG in VR condition

    Sensitivity and specificity of the TUG and TUG VR conditions

    Time frame: 1 year follow-up

  3. Correlation between TUG and TUG VR times and fall follow-up

    Time frame: 1 year follow-up

  4. Kinematics analysis

    Measurement of full body motion (coordinates on x, y, z axis) in function of the time during the virtual reality tasks

    Time frame: Baseline

  5. Kinetics analysis

    Measurement of plantar pressure evolution (force in Newton) in function of the time during the virtual reality tasks

    Time frame: Baseline

  6. Physiological analysis 1

    Measurement of heart pace evolution (bpm) in function of the time during the virtual reality tasks

    Time frame: Baseline

  7. Physiological analysis 2

    Measurement of breathing evolution (frequence) in function of the time during the virtual reality tasks

    Time frame: Baseline

  8. Physiological analysis 3

    Measurement of galvanic skin response evolution (µSiemens) in function of the time during the virtual reality tasks

    Time frame: Baseline

  9. Visual attention analysis

    Measurement of the gaze focused on virtual objects parameters (number of gazed on each object and time spend focused on the said object)

    Time frame: Baseline

  10. Psychology analysis 1

    Measurement of the fear of falling (Fall Efficacy Scale-International from Tinetti with a score from 16 to 64)

    Time frame: Baseline

  11. Psychology analysis 2

    Measurement of the fear of falling (Activities specific Balance Confidence - Scale from Powell \& Myers with a score from 0 to 45)

    Time frame: Baseline

  12. Psychology analysis 3

    Measurement of the coping strategies (Ways of Coping Checklist from Folkman \& Lazarus with scores from 1 to 5 for the remembered stress situation subjective evaluation, a score from 10 to 40 for the Problem item, a score from 9 to 36 for the Emotion item and a score from 8 to 32 for the encourgament item).

    Time frame: Baseline

  13. Automated learning and falling risk estimation

    Supervised learning with Support Vector Machine, Decision tree, Linear discriminant. Using machine learning algorithms is not a measurement but data processing compiling all the data from measurement and comparing them to the number of fall during the year follow up. Machine learning algorithms will learn from these data to classify any new participant into a profile "with a low risk of fall", "with a high risk of fall" or "without a risk of fall".

    Time frame: up to 3 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03848897
Lead sponsor
Central Hospital, Nancy, France
Collaborators
OHS - Office d'Hygiène Sociale, ONPA - Office Nancéien des Personnes Agées, University of Lorraine
Responsible party
Sponsor
First posted
Feb 21, 2019
Start date
Apr 30, 2019 (estimated)
Primary completion
Jun 30, 2020 (estimated)
Completion
Jun 30, 2022 (estimated)
Last update
Apr 16, 2019

Study contacts

Philippe Perrin, MD PhD Prof
Contact
philippe.perrin@univ-lorraine.fr
+33383154650

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion